Exploring the Complexities of Myasthenia Gravis: Antibody-Positive and Seronegative Variants
Myasthenia Gravis (MG) is an autoimmune disorder that presents a unique challenge to neurologists due to its varied manifestations and the intricate nature of its diagnosis and treatment. Traditionally understood as a disorder affecting the communication between nerves and muscles, MG leads to muscle weakness and fatigue. However, a closer look reveals that MG can be categorized into two distinct types based on the presence or absence of specific antibodies: Antibody-Positive MG and Seronegative MG. This distinction not only sheds light on the underlying pathophysiology of the disease but also influences the approach to diagnosis and treatment.